PD-L1 testing in advanced gastric cancer—what physicians who treat this disease must know—a literature review

BACKGROUND AND OBJECTIVE: Immune checkpoint inhibition has shed light on a new era in cancer therapy, and randomized clinical trials have demonstrated that a meaningful portion of the overall population of metastatic gastric cancer (GC) patients may derive clinical benefit from immunotherapy, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Peixoto, Renata D’Alpino, Mathias-Machado, Maria Cecilia, Jácome, Alexandre, Gil, Mariana, Fogacci, João, Sodré, Bárbara, Passarini, Thaís, Chaves, Aline, Diniz, Paulo Henrique, Lino, Flora, Palladino, Alexandre, Souto, Mirela, de Castro, Ana Carolina, Garicochea, Bernardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331768/
https://www.ncbi.nlm.nih.gov/pubmed/37435200
http://dx.doi.org/10.21037/jgo-22-1133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331768/
https://www.ncbi.nlm.nih.gov/pubmed/37435200
http://dx.doi.org/10.21037/jgo-22-1133

Ejemplares similares